SELEX-HTCFQ Platform: Developing DNA Enhancers of ADAR1 to Suppress ZBP1-Dependent Immunopathology
Yafei Hu, Riming Huang, Yifan Wang, Han Zhu, Qing‐Qing Ye, Juan-Mei Wang, Zhuhua Yao, Zhi‐Gang Wang, Dai‐Wen Pang, Shu‐Lin Liu
The paper develops a SELEX-HTCFQ platform to identify ADAR1-specific enhancers that suppress ZBP1-dependent immunopathology by selectively modulating ADAR1 activity.
Journal of the American Chemical Society · Nov 21, 2025Peer-reviewedBiochemistry